Skip to main content
. 2020 Mar 29;10(3):e036159. doi: 10.1136/bmjopen-2019-036159

Table 4.

Results from univariate analysis for each category of medicines and health outcome

Survival 1 year
95% CI
Survival 2 year
95% CI
ADL independent 1 year
95% CI
mRS 0–2 1 year
95% CI
OR Lower Upper P value OR Lower Upper P value OR Lower Upper P value OR Lower Upper P value
Group of medicines
 Oral anticoagulants 0.61 0.56 0.66 <0.001 0.61 0.56 0.66 <0.001 0.76 0.66 0.88 <0.001 0.66 0.59 0.75 <0.001
 Statins 1.18 1.11 1.25 <0.001 1.13 1.07 1.19 <0.001 0.93 0.86 1.01 0.082 0.94 0.87 1.00 0.050
 Drugs used for hypertension 0.42 0.40 0.45 <0.001 0.41 0.39 0.44 <0.001 0.56 0.51 0.60 <0.001 0.48 0.45 0.51 <0.001
 NSAIDs 1.44 1.31 1.59 <0.001 1.43 1.31 1.56 <0.001 1.08 0.95 1.22 0.235 1.08 0.98 1.19 0.109
 Antidepressants 0.60 0.56 0.64 <0.001 0.58 0.55 0.62 <0.001 0.47 0.42 0.51 <0.001 0.45 0.41 0.49 <0.001
 Drugs used in diabetes 0.80 0.75 0.86 <0.001 0.78 0.74 0.83 <0.001 0.67 0.61 0.74 <0.001 0.67 0.62 0.73 <0.001

NSAIDs, non-steroidal anti-inflammatory drugs.